The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...

Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Although adoption of a multiplex respiratory virus testing platform reduced antibiotic prescriptions ...

Hologic is acquiring molecular diagnostics firm Mobidiag Oy in an approximately $795 million deal that will give the women’s health company the capability to offer testing closer to patients with ...

The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...

GARDEN CITY, NY, Feb. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, has begun new saliva-based, viral RT-PCR multiplex-testing ...

DUBLIN--(BUSINESS WIRE)--The "Syndromic Multiplex Diagnostic Markets - Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) & by Country - With Market Analysis, Executive Guides ...

In the article accompanying this editorial, Gray et al 4 present the results of a survey of practicing oncologists at the Dana-Farber Cancer Institute (DFCI) that was conducted before the roll-out of ...

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that ...